◼ Archived
Health
🔮 fades ✓
Optogenetic Therapy for Restoring Aspects of Visual Function
Scientists have restored limited vision in blind patients using GS030 optogenetic gene therapy and specialized goggles.
Gene Therapy
21 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Gene Therapy
This hub groups 21 separate news trends connected to Gene Therapy, spanning June 21, 2026 through October 11, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 146 article observations and 143 source signals, led by Health, Business, Science coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Health
🔮 fades ✓
Gene therapy can partly restore sight in blind people, researchers reveal
Gene therapy shows promise in restoring sight in blind people, researchers reveal.
◼ Archived
Health
🔮 fades ✓
Why old dogs might be able to teach Alzheimer’s researchers new tricks
9 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
A one-time treatment may fix damaged adult retinas
4 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Scientists May Have Found a Way to Make Damaged Adult Retinas Repair Themselves
A breakthrough gene therapy that restored neural connections in adult retinas offers a potential one-time treatment to repair damage and restore lost sight.
◼ Archived
Business
🔮 fades ✓
FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease
8 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
‘Curved Air’ Review: A Mutation’s Painful Legacy
A wave of sickle‑cell breakthroughs hits headlines as a gene therapy promises longer lives for patients.
◼ Archived
Science
🔮 fades ✓
Highly efficient base editing at PCSK9 and normal human embryo development
A breakthrough base‑editing tool now tweaks a disease gene in embryos without disrupting development, reviving hopes—and debates—about germline therapy.
◼ Archived
Business
🔮 fades ✓
An Experimental Single-Time Treatment Slashed Cholesterol for a Year
A single-time gene therapy treatment has shown sustained cholesterol reduction for a year, sparking investor interest and medical hope.
◼ Archived
Business
FDA pauses Regenxbio gene therapy trial again due to safety concerns
The FDA has halted Regenxbio's gene therapy trial for Hunter Syndrome for the second time, sending the company's stock tumbling.
◼ Archived
Science
🔮 fades ✓
New lipid nanoparticle delivers capped circular RNA for longer-lasting gene expression
A new lipid nanoparticle promises to extend the duration of gene expression, potentially revolutionizing RNA therapies.
◼ Archived
Business
Exclusive: Third death in China's popular but opaque trials revealed, this time in CAR-T
A third death in China's gene therapy trials raises questions about the safety and oversight of these experimental treatments.
◼ Archived
Health
Procognitive restoration of PV neuron plasticity in neurodevelopmental disorders
Researchers have identified a gene therapy that reverses autism and seizures in adults by restoring brain plasticity.
◼ Archived
Health
🔮 fades ✓
The ethical perils of gene therapy
A child's death in China raises questions about the ethics of gene therapy.
◼ Archived
Health
🔮 fades ✗
Targeting Allele-Specific Faulty MRNA In SCNA2 Mutation Patients
8 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Boston Children’s and the Broad Institute partner on new center for rare genetic diseases
Three major institutions have launched the Center for Therapeutic Genetics to develop medicines for rare and ultra-rare genetic diseases.
◼ Archived
Business
🔮 fades ✓
MeiraGTx scores $400M from Oberland Capital to help get 2 gene therapies to commercialization
MeiraGTx has secured significant new funding from Oberland Capital to advance two gene therapies toward commercialization.
◼ Archived
Business
🔮 fades ✓
FDA’s top gene therapy regulator is leaving his role
The FDA's top gene therapy regulator is stepping down, amid a significant setback for a kidney disease drug.
◼ Archived
Health
🔮 fades ✓
Louisiana Notches a Sickle Cell First
A Louisiana man is the first in the state to be functionally cured of sickle cell disease.
◼ Archived
Business
🔮 fades ✓
Exclusive | FDA Will Reverse Rejection of Third Rare-Disease Drug, Regenxbio Says
The FDA is reversing its rejection of Regenxbio's gene therapy for Hunter syndrome, marking the third such reversal for rare-disease drugs.
◼ Archived
Business
🔮 fades ✓
Scientists test first-ever therapy to make human cells young again
Human trials have officially commenced for the first-ever gene therapy designed to rejuvenate human cells and reverse aging.